posted on 2019-05-13, 08:57authored byMV Holmes, CE Dale, L Zuccolo, RJ Silverwood, Y Guo, Z Ye, D Prieto-Merino, A Dehghan, S Trompet, A Wong, A Cavadino, D Drogan, S Padmanabhan, S Li, A Yesupriya, M Leusink, J Sundstrom, JA Hubacek, H Pikhart, DI Swerdlow, AG Panayiotou, SA Borinskaya, C Finan, S Shah, KB Kuchenbaecker, T Shah, J Engmann, L Folkersen, P Eriksson, F Ricceri, O Melander, C Sacerdote, DM Gamble, S Rayaprolu, OA Ross, S McLachlan, O Vikhireva, I Sluijs, RA Scott, V Adamkova, L Flicker, FMV Bockxmeer, C Power, P Marques-Vidal, T Meade, MG Marmot, JM Ferro, S Paulos-Pinheiro, SE Humphries, PJ Talmud, I Mateo Leach, N Verweij, A Linneberg, T Skaaby, PA Doevendans, MJ Cramer, P van der Harst, OH Klungel, NF Dowling, AF Dominiczak, M Kumari, AN Nicolaides, C Weikert, H Boeing, S Ebrahim, TR Gaunt, JF Price, L Lannfelt, A Peasey, R Kubinova, A Pajak, S Malyutina, MI Voevoda, A Tamosiunas, AH Maitland-van der Zee, PE Norman, GJ Hankey, MM Bergmann, A Hofman, OH Franco, J Cooper, J Palmen, W Spiering, PA de Jong, D Kuh, R Hardy, AG Uitterlinden, MA Ikram, I Ford, E Hyppönen, OP Almeida, NJ Wareham, K-T Khaw, A Hamsten, LLN Husemoen, A Tjønneland, JS Tolstrup, E Rimm, JWJ Beulens, WMM Verschuren, NC Onland-Moret, MH Hofker, SG Wannamethee, PH Whincup, R Morris, AM Vicente, H Watkins, M Farrall, JW Jukema, J Meschia, LA Cupples, SJ Sharp, M Fornage, C Kooperberg, AZ LaCroix, JY Dai, MB Lanktree, DS Siscovick, E Jorgenson, B Spring, J Coresh, YR Li, SG Buxbaum, PJ Schreiner, RC Ellison, MY Tsai, SR Patel, S Redline, AD Johnson, RC Hoogeveen, H Hakonarson, JI Rotter, E Boerwinkle, PIW de Bakker, M Kivimaki, FW Asselbergs, N Sattar, DA Lawlor, J Whittaker, G Davey Smith, K Mukamal, BM Psaty, JG Wilson, LA Lange, A Hamidovic, AD Hingorani, BG Nordestgaard, M Bobak, DA Leon, C Langenberg, TM Palmer, AP Reiner, BJ Keating, F Dudbridge, JP Casas, InterAct Consortium
OBJECTIVE: To use the rs1229984 variant in the alcohol dehydrogenase 1B gene (ADH1B) as an instrument to investigate the causal role of alcohol in cardiovascular disease. DESIGN: Mendelian randomisation meta-analysis of 56 epidemiological studies. PARTICIPANTS: 261 991 individuals of European descent, including 20 259 coronary heart disease cases and 10 164 stroke events. Data were available on ADH1B rs1229984 variant, alcohol phenotypes, and cardiovascular biomarkers. MAIN OUTCOME MEASURES: Odds ratio for coronary heart disease and stroke associated with the ADH1B variant in all individuals and by categories of alcohol consumption. RESULTS: Carriers of the A-allele of ADH1B rs1229984 consumed 17.2% fewer units of alcohol per week (95% confidence interval 15.6% to 18.9%), had a lower prevalence of binge drinking (odds ratio 0.78 (95% CI 0.73 to 0.84)), and had higher abstention (odds ratio 1.27 (1.21 to 1.34)) than non-carriers. Rs1229984 A-allele carriers had lower systolic blood pressure (-0.88 (-1.19 to -0.56) mm Hg), interleukin-6 levels (-5.2% (-7.8 to -2.4%)), waist circumference (-0.3 (-0.6 to -0.1) cm), and body mass index (-0.17 (-0.24 to -0.10) kg/m(2)). Rs1229984 A-allele carriers had lower odds of coronary heart disease (odds ratio 0.90 (0.84 to 0.96)). The protective association of the ADH1B rs1229984 A-allele variant remained the same across all categories of alcohol consumption (P=0.83 for heterogeneity). Although no association of rs1229984 was identified with the combined subtypes of stroke, carriers of the A-allele had lower odds of ischaemic stroke (odds ratio 0.83 (0.72 to 0.95)). CONCLUSIONS: Individuals with a genetic variant associated with non-drinking and lower alcohol consumption had a more favourable cardiovascular profile and a reduced risk of coronary heart disease than those without the genetic variant. This suggests that reduction of alcohol consumption, even for light to moderate drinkers, is beneficial for cardiovascular health.
Funding
CCBYNC Open access
Research
Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data
BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g4164 (Published 10 July 2014)
Cite this as: BMJ 2014;349:g4164
Article
Related content
Metrics
Responses
Peer review
Michael V Holmes, assistant professor (joint first author)123, Caroline E Dale, research fellow (joint first author)4, Luisa Zuccolo, population health scientist fellow5, Richard J Silverwood, lecturer in medical statistics46, Yiran Guo, research associate78, Zheng Ye, investigator scientist9, David Prieto-Merino, lecturer in medical statistics4, Abbas Dehghan, assistant professor10, Stella Trompet, senior researcher11, Andrew Wong, senior study manager12, Alana Cavadino, statistician13, Dagmar Drogan, scientist14, Sandosh Padmanabhan, reader15, Shanshan Li, postdoctoral research fellow16, Ajay Yesupriya, health scientist17, Maarten Leusink, doctoral candidate18, Johan Sundstrom, senior epidemiologist19, Jaroslav A Hubacek, senior scientist20, Hynek Pikhart, senior lecturer21, Daniel I Swerdlow, clinician scientist1, Andrie G Panayiotou, lecturer in public health22, Svetlana A Borinskaya, leading researcher23, Chris Finan, bioinformatician1, Sonia Shah, postdoctoral research fellow24, Karoline B Kuchenbaecker, research associate in genetic epidemiology25, Tina Shah, postdoctoral research fellow1, Jorgen Engmann, data manager1, Lasse Folkersen, postdoctoral research fellow26, Per Eriksson, professor of cardiovascular medicine26, Fulvio Ricceri, epidemiologist, research fellow28, Olle Melander, professor27, Carlotta Sacerdote, medical epidemiologist28, Dale M Gamble, researcher29, Sruti Rayaprolu, researcher30, Owen A Ross, associate professor30, Stela McLachlan, data manager31, Olga Vikhireva, research associate21, Ivonne Sluijs, assistant professor32, Robert A Scott, senior investigator scientist9, Vera A
History
Citation
BMJ, 2014, 349:g4164
Author affiliation
/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Department of Health Sciences